company background image
A258

Sejong Medical KOSDAQ:A258830 Stock Report

Last Price

₩4.05k

Market Cap

₩160.7b

7D

4.2%

1Y

94.7%

Updated

21 May, 2022

Data

Company Financials
A258830 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

A258830 Stock Overview

Sejong Medical Co., Ltd. develops, manufactures, and supplies laparoscopic surgery systems and equipment in South Korea.

Sejong Medical Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for Sejong Medical
Historical stock prices
Current Share Price₩4,050.00
52 Week High₩9,650.00
52 Week Low₩1,958.00
Beta0.67
1 Month Change-3.57%
3 Month Change-20.74%
1 Year Change94.71%
3 Year Change87.50%
5 Year Changen/a
Change since IPO-32.50%

Recent News & Updates

Mar 24
Sejong Medical (KOSDAQ:258830) Might Be Having Difficulty Using Its Capital Effectively

Sejong Medical (KOSDAQ:258830) Might Be Having Difficulty Using Its Capital Effectively

There are a few key trends to look for if we want to identify the next multi-bagger. Typically, we'll want to notice a...

Mar 02
Update: Sejong Medical (KOSDAQ:258830) Stock Gained 53% In The Last Year

Update: Sejong Medical (KOSDAQ:258830) Stock Gained 53% In The Last Year

A diverse portfolio of stocks will always have winners and losers. Of course, the aim of the game is to pick stocks...

Feb 11
Does The Market Have A Low Tolerance For Sejong Medical Co., Ltd.'s (KOSDAQ:258830) Mixed Fundamentals?

Does The Market Have A Low Tolerance For Sejong Medical Co., Ltd.'s (KOSDAQ:258830) Mixed Fundamentals?

With its stock down 7.5% over the past month, it is easy to disregard Sejong Medical (KOSDAQ:258830). We, however...

Shareholder Returns

A258830KR Medical EquipmentKR Market
7D4.2%-0.04%1.6%
1Y94.7%-5.8%-14.2%

Return vs Industry: A258830 exceeded the KR Medical Equipment industry which returned -5.8% over the past year.

Return vs Market: A258830 exceeded the KR Market which returned -14.2% over the past year.

Price Volatility

Is A258830's price volatile compared to industry and market?
A258830 volatility
A258830 Average Weekly Movement8.9%
Medical Equipment Industry Average Movement5.8%
Market Average Movement5.6%
10% most volatile stocks in KR Market10.4%
10% least volatile stocks in KR Market3.2%

Stable Share Price: A258830 is more volatile than 75% of KR stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: A258830's weekly volatility has decreased from 15% to 9% over the past year, but is still higher than 75% of KR stocks.

About the Company

FoundedEmployeesCEOWebsite
1996111Jaechul Leehttps://www.sejongmedical.com

Sejong Medical Co., Ltd. develops, manufactures, and supplies laparoscopic surgery systems and equipment in South Korea. It offers trocar, single port, specimen pouch, suction irrigation, suture loop, smoke filter, BUMI, and ETC products. Sejong Medical Co., Ltd.

Sejong Medical Fundamentals Summary

How do Sejong Medical's earnings and revenue compare to its market cap?
A258830 fundamental statistics
Market Cap₩160.69b
Earnings (TTM)-₩5.19b
Revenue (TTM)₩18.02b

8.9x

P/S Ratio

-31.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
A258830 income statement (TTM)
Revenue₩18.02b
Cost of Revenue₩9.41b
Gross Profit₩8.61b
Other Expenses₩13.81b
Earnings-₩5.19b

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-130.85
Gross Margin47.81%
Net Profit Margin-28.81%
Debt/Equity Ratio54.6%

How did A258830 perform over the long term?

See historical performance and comparison

Dividends

0.5%

Current Dividend Yield

-13%

Payout Ratio

Valuation

Is Sejong Medical undervalued compared to its fair value and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


2.89x

Price to Book (PB) ratio

Share Price vs. Fair Value

Below Fair Value: A258830 (₩4050) is trading above our estimate of fair value (₩461.5)

Significantly Below Fair Value: A258830 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: A258830 is unprofitable, so we can't compare its PE Ratio to the KR Medical Equipment industry average.

PE vs Market: A258830 is unprofitable, so we can't compare its PE Ratio to the KR market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate A258830's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: A258830 is overvalued based on its PB Ratio (2.9x) compared to the KR Medical Equipment industry average (2.4x).


Future Growth

How is Sejong Medical forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


4.5%

Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Sejong Medical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Sejong Medical performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-46.9%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: A258830 is currently unprofitable.

Growing Profit Margin: A258830 is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: A258830 is unprofitable, and losses have increased over the past 5 years at a rate of 46.9% per year.

Accelerating Growth: Unable to compare A258830's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A258830 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (17.5%).


Return on Equity

High ROE: A258830 has a negative Return on Equity (-10.67%), as it is currently unprofitable.


Financial Health

How is Sejong Medical's financial position?

Financial Health Score

3/6

Financial Health Score 3/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: A258830's short term assets (₩43.4B) exceed its short term liabilities (₩6.2B).

Long Term Liabilities: A258830's short term assets (₩43.4B) exceed its long term liabilities (₩29.5B).


Debt to Equity History and Analysis

Debt Level: A258830 has more cash than its total debt.

Reducing Debt: A258830's debt to equity ratio has increased from 13.6% to 54.6% over the past 5 years.

Debt Coverage: A258830's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: Insufficient data to determine if A258830's interest payments on its debt are well covered by EBIT.


Balance Sheet


Dividend

What is Sejong Medical current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


0.49%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: A258830's dividend (0.49%) isn’t notable compared to the bottom 25% of dividend payers in the KR market (0.85%).

High Dividend: A258830's dividend (0.49%) is low compared to the top 25% of dividend payers in the KR market (2.75%).


Stability and Growth of Payments

Stable Dividend: A258830 is not paying a notable dividend for the KR market, therefore no need to check if payments are stable.

Growing Dividend: A258830 is not paying a notable dividend for the KR market, therefore no need to check if payments are increasing.


Earnings Payout to Shareholders

Earnings Coverage: A258830 is not paying a notable dividend for the KR market.


Cash Payout to Shareholders

Cash Flow Coverage: A258830 is paying a dividend but the company has no free cash flows.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Jaechul Lee

no data

Tenure

Jaechul Lee is Chief Executive Officer of Sejong Medical Co., Ltd.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 22.9%.


Top Shareholders

Company Information

Sejong Medical Co., Ltd.'s employee growth, exchange listings and data sources


Key Information

  • Name: Sejong Medical Co., Ltd.
  • Ticker: A258830
  • Exchange: KOSDAQ
  • Founded: 1996
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: ₩160.692b
  • Shares outstanding: 39.68m
  • Website: https://www.sejongmedical.com

Number of Employees


Location

  • Sejong Medical Co., Ltd.
  • 11 Sinchon 2-ro
  • Paju-Si
  • Gyeonggi-do
  • 10880
  • South Korea

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/21 00:00
End of Day Share Price2022/05/20 00:00
Earnings2021/12/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.